Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

E Frei, C Visco, Z Y Xu-Monette, S Dirnhofer, K Dybkær, A Orazi, G Bhagat, E D Hsi, J H van Krieken, M Ponzoni, R S Go, M A Piris, M B Møller, K H Young, A Tzankov

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint Dive into the research topics of 'Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences